The streptococcal M protein: a highly versatile molecule
- PMID: 20347595
- DOI: 10.1016/j.tim.2010.02.007
The streptococcal M protein: a highly versatile molecule
Abstract
Interaction of the M-protein of group A Streptococcus (GAS) with its numerous host binding partners might assist the bacteria in evading host immune responses. Although the extensive diversity of this protein has been highlighted by different GAS typing schemes, most of the structural and functional information has been obtained from a limited number of types. Increasing numbers of epidemiological, clinical and biological reports suggest that the structure and function of the M protein is less conserved than previously thought. This review focuses on the known interactions between M proteins and host ligand proteins, emphasizing that our understanding of this well-studied molecule is fragmented.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.BMC Microbiol. 2006 Aug 9;6:71. doi: 10.1186/1471-2180-6-71. BMC Microbiol. 2006. PMID: 16895610 Free PMC article.
-
The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.Vaccine. 2010 Jan 22;28(4):883-5. doi: 10.1016/j.vaccine.2009.10.137. Epub 2009 Dec 4. Vaccine. 2010. PMID: 19963033 No abstract available.
-
Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development.Vaccine. 2008 Oct 29;26(46):5835-42. doi: 10.1016/j.vaccine.2008.08.037. Epub 2008 Sep 25. Vaccine. 2008. PMID: 18789365
-
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Expert Rev Vaccines. 2009 Dec;8(12):1705-20. doi: 10.1586/erv.09.133. Expert Rev Vaccines. 2009. PMID: 19905872 Review.
-
Lipid core peptide technology and group A streptococcal vaccine delivery.Expert Rev Vaccines. 2004 Feb;3(1):43-58. doi: 10.1586/14760584.3.1.43. Expert Rev Vaccines. 2004. PMID: 14761243 Review.
Cited by
-
Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019.Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2295-2303. doi: 10.1007/s10096-021-04279-2. Epub 2021 May 27. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34046804
-
Serological Evidence of Immune Priming by Group A Streptococci in Patients with Acute Rheumatic Fever.Front Microbiol. 2016 Jul 22;7:1119. doi: 10.3389/fmicb.2016.01119. eCollection 2016. Front Microbiol. 2016. PMID: 27499748 Free PMC article.
-
RocA Has Serotype-Specific Gene Regulatory and Pathogenesis Activities in Serotype M28 Group A Streptococcus.Infect Immun. 2018 Oct 25;86(11):e00467-18. doi: 10.1128/IAI.00467-18. Print 2018 Nov. Infect Immun. 2018. PMID: 30126898 Free PMC article.
-
SIgA structures bound to Streptococcus pyogenes M4 and human CD89 provide insights into host-pathogen interactions.Nat Commun. 2023 Oct 23;14(1):6726. doi: 10.1038/s41467-023-42469-y. Nat Commun. 2023. PMID: 37872175 Free PMC article.
-
A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.J Infect Dis. 2014 Oct 15;210(8):1325-38. doi: 10.1093/infdis/jiu260. Epub 2014 May 5. J Infect Dis. 2014. PMID: 24799598 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical